borderline significanceP = 0.052
In contrast, HER2 amplifications and BRAF mutations were associated with KRAS wild type with borderline significance ( P = 0.052 and 0.094, respectively).
In contrast, HER2 amplifications and BRAF mutations were associated with KRAS wild type with borderline significance ( P = 0.052 and 0.094, respectively).
In our KRAS mutation subgroup analysis, mutation of KRAS codon 61 tended to be associated with shorter overall survival, but it did not reach statistical significance.